#NEWS: Results from Novo Nordisk’s #hemophilia research published in @NEJM highlights the potential of an investigational preventive bleed treatment option to help people living with hemophilia A, with or without inhibitors. Read more: bit.ly/4mXWOEl #RareDisease

@novonordiskus @NEJM Promising progress. Preventive options in hemophilia A could significantly improve quality of life and reduce long-term complications.